Vivo Capital

Latest statistics and disclosures from Vivo Capital's latest quarterly 13F-HR filing:

Vivo Capital portfolio companies for December 2016 quarter

Company (Ticker) Portfolio Weight Share Count Price Last Trade
Aclaris Therapeutics 29.67 3.28M -21.00% 27.14 0.00
Ascendis Pharma A S 11.91 1.77M 20.24 0.00
Codexis Inc 8.11 5.29M 4.60 0.00
Nabriva Therapeutics Ag 7.98 4.02M +27.00% 5.96 0.00
Eiger Biopharmaceuticals 6.93 1.79M 11.65 0.00
Aimmune Therapeutics 5.19 763009 20.45 0.00
Advanced Accelerat spon ads each rep 2 ord shs 4.06 455798 26.76 0.00
Trevena 3.38 1.73M 5.88 0.00
Foamix Pharmaceuticals Ltd shs 3.16 855000 11.10 0.00
Regenxbio Inc equity us cm 3.11 502863 -49.00% 18.55 0.00
Agile Therapeutics 2.87 1.51M -25.00% 5.70 0.00
Colucid Pharmaceuticals 2.73 225000 36.40 0.00
Strongbridge Bioph shs usd 2.40 3.00M NEW 2.40 0.00
Capnia 2.01 7.46M 0.81 0.00
Biopharmx 1.58 12.81M NEW 0.37 0.00
Akari Therapeutics 1.24 527842 7.04 0.00
Pronai Therapeutics 1.21 2.44M 1.49 0.00
Kalvista Pharmaceuticals 0.71 300325 NEW 7.07 0.00
Sunesis Pharmaceuticals Inc Ne 0.60 500000 NEW 3.62 0.00
Revance Therapeutics 0.53 77373 20.70 0.00
Dynavax Technologies 0.47 359828 3.95 0.00
Ocera Therapeutics 0.11 153331 2.10 0.00
Capnia Inc Common Stock Warrants 0.03 943858 0.08 0.00
Zosano Pharma 0.03 98515 0.78 0.00

Past 13F-HR SEC Filings for Vivo Capital

View All Filings